s-(1,2-dichlorovinyl)cysteine has been researched along with captax in 1 studies
Studies (s-(1,2-dichlorovinyl)cysteine) | Trials (s-(1,2-dichlorovinyl)cysteine) | Recent Studies (post-2010) (s-(1,2-dichlorovinyl)cysteine) | Studies (captax) | Trials (captax) | Recent Studies (post-2010) (captax) |
---|---|---|---|---|---|
154 | 1 | 15 | 161 | 0 | 60 |
Protein | Taxonomy | s-(1,2-dichlorovinyl)cysteine (IC50) | captax (IC50) |
---|---|---|---|
Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.74 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anders, MW; Elfarra, AA; Lash, LH | 1 |
1 other study(ies) available for s-(1,2-dichlorovinyl)cysteine and captax
Article | Year |
---|---|
Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine.
Topics: Animals; Benzothiazoles; Cysteine; Drug Synergism; Keto Acids; Kidney; Lyases; Male; Mitochondria; Oxygen Consumption; Rats; Thiazoles; Transaminases | 1987 |